Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Beyond Biopsy and Gluten-Free Diet
• Six Research Developments About Patients with HCC
• Biliary Stents Pose Relative Risks, Benefits to Patients Sergey V. Kantsevoy, MD, PhD
• Cortiment for UC Launches in Europe
• FDA Approves Eclipse System for Fecal Incontinence in Women
• FDA Grants Breakthrough Therapy Designation to Obeticholic Acid for NASH
• Reolysin Receives Orphan Drug Designation for Ovarian, Pancreatic Cancers
• Two HCV Treatments Lose Breakthrough Therapy Designation
• Working to Meet the Unmet Need of Celiac Treatment
• HCV Consults: Volume 1, Number 2
• GI Experts Offer Recommendations for Cellvizio
• Amitiza Benefited Patients with Chronic Idiopathic Constipation
• Cetuximab Plus FOLFIRI Only Effective in RAS Wild-type Metastatic CRC
• Chronic Narcotic use Common Among Pediatric IBD Patients
• High Childhood BMI may Increase Esophageal Cancer Risk as Adult
• Low Serum Sodium, High MELD Score Increased Liver Transplant Survival
• Measuring Mucosal Impedance Differentiated GERD, Non-GERD, EoE
• Quadruple Therapy Yields High SVR Rates in Patients with HCV
• Reaching SVR After Antiviral Therapy Improves Advanced Fibrosis Survival
• Anti-MAdCAM Antibody Induces Remission in UC
• FMT not Effective in Active UC Patients
• Many Europeans with Mild-to-Moderate Ulcerative Colitis Nonadherent to Therapy
• No Increased Risk for Adverse Pregnancy, Developmental Outcomes with Humira, Remicade
• NSAIDs, PPIs, SSRIs Increase Risk for Microscopic Colitis
• CCFA, AGA, Janssen Launch new Program for Epigenetic IBD Research
• CDC: Nearly 500,000 C. difficile Infections in US in 2011
• Celiac Disease Prevalence More Than Doubled in US Since 1988
• EM-guided Nasoenteral Feeding Tube Placement Comparably Safe, Effective
• High SVR Rates Achieved in HCV Patients Taking Investigational Antiviral